Exendin-4, a GLP-1 receptor agonist, stimulates entero-insular axis in the rat, through a mechanism involving adrenal medulla.

Accession number;02A0375388
Title;Exendin-4, a GLP-1 receptor agonist, stimulates entero-insular axis in the rat, through a mechanism involving adrenal medulla.
Author; MALENDOWICZ L K (School Of Medicine, Pol) NOWAK K W (August Cieszkowski Univ. Agriculture, Poznan, Pol) ZYTERSKA A (August Cieszkowski Univ. Agriculture, Poznan, Pol) NUSSDORFER G G (Univ. Padua, Padua, Ita) MACCHI C (Univ. Padua, Padua, Ita) NOWAK M (School Of Medicine, Pol)
Journal Title;Biomed Res
Journal Code:Z0236B
ISSN:0388-6107
VOL.22;NO.6;PAGE.295-297(2001)
Figure&Table&Reference;FIG.1, REF.11
Pub. Country;Japan
Language;English
Abstract;Glucagon-like peptide-1(GLP-1) is known to lower blood glucose level, the effect depending on the stimulation of insulin and the inhibition of glucagon secretion. Due to the rapid inactivation of GLP-1 by dipeptidyl peptidase-IV(DPP-IV), its biological action is very short. Hence, we investigated the effect on rat entero-insular axis of exendin-4, a DPP-IX-resistant agonist of GPL-1 receptors. As expected the bolus administration of exendin-4 (12nmol/kg) increased the plasma concentration of insulin and decreased the blood levels of both glucagon and leptin in normal rats; however, GLP-1 raised glycemia. Exendin-4 did not evoke any effect in rats bearing enucleated-regenerated adrenals deprived of medullary tissue, thereby suggesting that its stimulating effect of entero-insular axis occurs via an indirect mechanism probably involving medullary catecholamines. Catecholamines are potent stimulator of hepatic glycogenolysis, and this may tentatively explain the hyperglycemizing effect of exendin-4. (author abst.)